Praxis Precision Medicines, Inc.
PRAX
$37.20
$0.792.17%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 249.53% | -16.93% | 20.97% | 221.38% | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 249.53% | -16.93% | 20.97% | 221.38% | -- |
| Cost of Revenue | 75.66% | 19.15% | -17.75% | 1.83% | -23.76% |
| Gross Profit | -70.61% | -19.89% | 18.27% | -0.09% | 25.91% |
| SG&A Expenses | 33.89% | 13.96% | -10.80% | -21.53% | -28.90% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 62.02% | 17.50% | -15.57% | -27.64% | -39.52% |
| Operating Income | -58.39% | -17.98% | 15.91% | 28.57% | 40.67% |
| Income Before Tax | -48.30% | -9.77% | 21.13% | 31.40% | 42.40% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -48.30% | -9.77% | 21.13% | 31.40% | 42.40% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -48.30% | -9.77% | 21.13% | 31.40% | 42.40% |
| EBIT | -58.39% | -17.98% | 15.91% | 28.57% | 40.67% |
| EBITDA | -58.65% | -18.04% | 15.96% | 28.64% | 40.75% |
| EPS Basic | 56.59% | 69.41% | 77.34% | 72.46% | 66.15% |
| Normalized Basic EPS | 56.25% | 69.04% | 77.13% | 72.10% | 65.77% |
| EPS Diluted | 56.59% | 69.41% | 77.34% | 72.46% | 66.15% |
| Normalized Diluted EPS | 56.25% | 69.04% | 77.13% | 72.10% | 65.77% |
| Average Basic Shares Outstanding | 172.33% | 197.39% | 252.63% | 186.34% | 113.89% |
| Average Diluted Shares Outstanding | 172.33% | 197.39% | 252.63% | 186.34% | 113.89% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |